Akebia Therapeutics Inc (NASDAQ:AKBA)

Akebia Therapeutics Inc (NASDAQ:AKBA)


Share Price
$ 3.78
Change
-0.1 (-2.58 %)
Market Cap
$445.52 m
Proactive Investors - Run By Investors For Investors

Akebia Therapeutics Inc

Based in Cambridge, Massachusetts, Akebia Therapeutics Inc. works to discover and develop therapeutic solutions leveraging the potential of hypoxia inducible factor (HIF) biology. 

EPIC: AKBA
Market: NASDAQ:AKBA
52-week High/Low: $10.730 / $3.725
Sector: Pharmaceuticals
Market Cap: $445.52 m
Website: akebia.com
col 3
col 4
col 5
col 6

Akebia Therapeutics Inc Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use